(2023)
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer.
Oncology Research.
31,
6
(2023)
The Optimal Tumor Mutational Burden Cutoff Value as a Novel Marker for Predicting the Efficacy of Programmed Cell Death-1 Checkpoint Inhibitors in Advanced Gastric Cancer.
JOURNAL OF GASTRIC CANCER.
23,
3
(2022)
Clinical Significance of Preoperative Hematological Parameters in Patients with D2‐Resected, Node‐Positive Stomach Cancer.
BIOMEDICINES.
10,
7
(2022)
A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer.
CANCER RESEARCH AND TREATMENT.
-,
-
(2022)
Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
ANNALS OF SURGICAL ONCOLOGY.
-,
-
(2022)
Safety and anti-tumor effects of vismodegib in patients with refractory advanced gastric cancer: A single-arm phase-II trial.
JOURNAL OF CANCER.
13,
4
(2022)
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.
JOURNAL FOR IMMUNOTHERAPY OF CANCER.
10,
7
(2021)
The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers.
FRONTIERS IN ONCOLOGY.
11,
(2021)
Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.
CANCER DISCOVERY.
11,
9
(2021)
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial.
ANNALS OF ONCOLOGY.
32,
3
(2021)
Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
GASTRIC CANCER.
24,
2
(2021)
Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial.
GENOME MEDICINE.
13,
1
(2021)
Impact of radiotherapy on kidney function among patients who received adjuvant treatment for gastric cancer: Logistic and linear regression analyses.
CANCERS.
13,
1
(2021)
Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as Second-line Therapy for Patients with Metastatic Colorectal Cancer.
JOURNAL OF CANCER.
12,
2
(2020)
Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY.
12,
-
(2020)
Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors.
EXPERT OPINION ON INVESTIGATIONAL DRUGS.
29,
9
(2020)
Effect of baseline sarcopenia on adjuvant treatment for D2 dissected gastric cancer: Analysis of the ARTIST phase III trial.
RADIOTHERAPY AND ONCOLOGY.
152,
-
(2020)
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY.
12,
(2020)
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
GASTRIC CANCER.
23,
3
(2020)
Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients.
TARGETED ONCOLOGY.
15,
2
단행본
(2003)
종양표지자.
일조각.
단독
특허/프로그램
암의 복막 전이 진단을 위한 MCT4의 용도
(Uses of MCT4 for Diagnosing Peritoneal Metastasis).
10-2016-0085613.
20191122.
대한민국
위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
{MARKER FOR PREDICTING STOMACH CANCER PROGNOSIS AND METHOD FOR PREDICTING STOMACH CANCER PROGNOSIS}.
11849123.2.
20180808.
스페인
위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
{MARKER FOR PREDICTING STOMACH CANCER PROGNOSIS AND METHOD FOR PREDICTING STOMACH CANCER PROGNOSIS}.
11849123.2.
20180808.
독일
위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
{MARKER FOR PREDICTING STOMACH CANCER PROGNOSIS AND METHOD FOR PREDICTING STOMACH CANCER PROGNOSIS}.
11849123.2.
20180808.
폴란드
학술회의논문
(2009)
MET amp;ification by qPCR predicts poor outcome in gastric cancer: a novel prognostic marker and a potential therapeutic target.
EUROPEAN JOURNAL OF CANCER.
독일
(2009)
Prognostic model to preict outcomes in pancreatic adenocarcomoma patients who recevied surgical resection with curative intent.
EUROPEAN JOURNAL OF CANCER SUPPLEMENTS.
독일
(2009)
Impact of MET Amplification on Gastic Cancer: A Novel Prognostic Marker and A Potentoal Therapeutic Target..
100th AACR annual meeting.
미국
(2009)
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer..
2009 Gastroinotestinal Cancers Symposiium.
미국
(2008)
Improved Brain Metastasis Out comes in HER2-overexpressing Breast Cancer Patients after Introduction of Trastuzumab.
한국임상암학회.
대한민국
(2008)
Is Tumor Marker Surge during Chemotherapy in Metastatic Breast Cancer an Adverse Predictor of Treatment Response?.
Korean Association for Clinical Oncology.
대한민국
(2008)
The Role of 18F-FDG-PET in Identification of Responders to chemoradiation Therapy for the Squamous Cell Carcinoma of Esophagus.
한국임상암학회.
대한민국
(2008)
Treatment Outcomes and Clinicopathologic Characteristics of Triple-negative Breast Cancer Patients who Received Platinum-containing chemotherapy.
Korea Association for Clinical Oncology.
대한민국
(2008)
Esophagorespiratory Fistula in patients with esophageal cancer.
The Korean Journal of Medicine.
대한민국
(2008)
The Role of 18F-FDG-PET in Identification of Responders to chemoradiation Therapy for the Squamous Cell Carcinoma of Esophagus.
대한내과학회 추계학술대회.
대한민국
(2008)
Clinical outcomes of metastatic breast cancer patients with triple-negative phenotype who received platinum-containing chemothetapy.
Journal of Clinical Oncology.
미국
(2008)
A Phase I/II Trial of docetaxel and oxaliplatin in patienes with advanced gastric cancer.
ASCO.
미국
(2008)
A Phase II study of oxaliplatin in combination with doxorubicine as first-line chemotherapy in patients with inoperable hepatocellular carcioma..
ASCO.
미국
(2007)
Changing the natural history of advanced non-small cell lung cancer with gefitinib?A single-center experience in Korea.
Journal of Thoracic Oncology.
대한민국
(2007)
Prognostic significance of L1 cell adhesion molecule(CAM)expression in Pulmonary neuroendocrine tumors.
Journal of Thoracic Oncology.
대한민국
(2007)
A RANDOMIZED MULTI-CENTER PHASE Ⅱ TRIAL OF CAPECITABINE(X)VERSUS S-1 AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH METASTATIC OR RECURRENT UNRESECTABLE GASTRIC CANCER.
Annals of Oncology.
스페인
(2007)
BONE MARROW METASTASES OF GASTRIC ADENOCARCINOMA:A SINGLE INSTITUTION EXPERIENCE.
Annals of Oncology.
스페인
(2007)
PRELIMINARY RESULTS FROM A PHASE Ⅱ STUDY OF SUNITINB IN PATIENTS WITH GASTRIC CANCER AFTER CHEMOTHERAPY FAILURE.
Annals of Oncology.
스페인
(2007)
A RANDOMIZED MULTI-CENTER PHASE Ⅱ TRIAL OF CAPECITABINE(X)VERSUS S-1 AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH METASTATIC OR RECURRENT UNRESECTABLE GASTRIC CANCER.
Journal of Clinical Oncology..
미국
(2007)
A multi-center phase Ⅱstudy of S-1 plus paclitaxel as first-line therapy in patients with advanced or relapsed gastric cancer..
Journal of Clinical Oncology..
미국
